Dossenheim, Germany

Stefan Dübel


Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 82(Granted Patents)


Location History:

  • Heidelberg, DE (2001)
  • Dossenheim, DE (2002 - 2004)

Company Filing History:


Years Active: 2001-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Stefan Dübel

Introduction

Stefan Dübel is a prominent inventor based in Dossenheim, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of phagemids for antibody screening. With a total of 3 patents, his work has advanced the methods used to select specific antibodies from large gene libraries.

Latest Patents

One of Dübel's latest patents involves a phagemid that expresses an antibody fused to the coliphage pIII protein. This innovative phagemid is designed for selecting specific antibodies from large gene libraries using small quantities of antigen. The antibody-pIII gene can be strongly repressed, allowing for the amplification of antibody libraries without the risk of deletion mutants predominating. After induction, this method enables the expression of large quantities of the fusion protein, showcasing its potential in antibody research.

Career Highlights

Throughout his career, Stefan Dübel has worked with notable companies such as Dade Behring Marburg GmbH and the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts. His experience in these organizations has contributed to his expertise in the field of biotechnology and patent development.

Collaborations

Dübel has collaborated with several professionals in his field, including Melvyn Little and Iris Klewinghaus. These partnerships have likely enhanced his research and innovation efforts.

Conclusion

Stefan Dübel's contributions to biotechnology, particularly through his patented phagemids for antibody screening, highlight his role as an influential inventor. His work continues to impact the field and advance the methods used in antibody research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…